Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 15 (8) , 1132-1137
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial FibrillationJACC, 2013
- Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysisJournal of the American Heart Association, 2013
- Biomarkers in atrial fibrillation: a clinical reviewEuropean Heart Journal, 2013
- NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolationJournal of Interventional Cardiac Electrophysiology, 2011
- Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillationCardiovascular Research, 2010
- Natriuretic Peptides: Their Structures, Receptors, Physiologic Functions and Therapeutic Applications2009
- The role of natriuretic peptides in cardioprotectionCardiovascular Research, 2006
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Heritability and Genetic Linkage of Plasma Natriuretic Peptide LevelsCirculation, 2003
- Endothelin System in Human Persistent and Paroxysmal Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2001